primary PCI
Showing 26 - 50 of >10,000
AMI Trial in Shenyang (Baduanjin sequential therapy, Aerobic exercise)
Recruiting
- AMI
- Baduanjin sequential therapy
- Aerobic exercise
-
Shenyang, Liaoning, ChinaGeneral Hospital of Shenyang Military Region
Jan 9, 2022
ST-elevation Myocardial Infarction Trial in Caen (cangrelor perfusion during PCI, standard PCI)
Recruiting
- ST-elevation Myocardial Infarction
- cangrelor perfusion during PCI
- standard PCI
-
Caen, FranceCAEN University Hospital
Jun 23, 2021
STEMI - ST Elevation Myocardial Infarction Trial in Beijing (Bivalirudin, Enoxaparin, Unfractionated heparin)
Active, not recruiting
- STEMI - ST Elevation Myocardial Infarction
- Bivalirudin
- +5 more
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Apr 10, 2022
Out-Of-Hospital Cardiac Arrest, Acute Coronary Syndrome Trial in Ljubljana (Cangrelor 50 MG)
Completed
- Out-Of-Hospital Cardiac Arrest
- Acute Coronary Syndrome
- Cangrelor 50 MG
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Dec 2, 2021
ST Elevation Myocardial Infarction, Coronary Artery Disease, Distal Transradial Artery Trial in Charleroi, Patras (Coronary
Not yet recruiting
- ST Elevation Myocardial Infarction
- +6 more
- Coronary angiography +/- percutaneous coronary intervention
-
Charleroi, Belgium
- +1 more
Nov 8, 2022
ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Recombinant Staphylokinase, Normal Saline)
Active, not recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Recombinant Staphylokinase
- Normal Saline
-
Nanjing, Jiangsu, China
- +7 more
Jan 30, 2023
Coronary Artery Disease, Ischemic Heart Disease, Myocardial Infarction Trial in Jerusalem (Culprit-first PCI)
Recruiting
- Coronary Artery Disease
- +4 more
- Culprit-first PCI
-
Jerusalem, IsraelShaare Zedek Medical Center
Jun 8, 2022
Should Integrilin beIntegral Part of Adjunctive Therapy in
Withdrawn
- ST-elevation Myocardial Infarction
- Acute Myocardial Infarction
-
Washington, District of ColumbiaWashington Hospital Center
Jun 30, 2021
Myocardial Infarction Trial in Seoul (Autologous peripheral blood-derived tolerogenic dendritic cells)
Recruiting
- Myocardial Infarction
- Autologous peripheral blood-derived tolerogenic dendritic cells
-
Seoul, Korea, Republic ofEun Ho Choo
Sep 21, 2022
Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in
Active, not recruiting
- Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 20, 2023
Heart Rate Variability in Acute Myocardial Infarction
Not yet recruiting
- Myocardial Infarction
- Autonomic Dysfunction
- Heart rate variability measurement
- Percutaneous coronary intervention
-
Iaşi, RomaniaDepartment of Interventional Cardiology, Institute of Cardiovasc
Oct 29, 2021
Acute Myocardial Infarction, Coronary Artery Disease Trial in Belgrade (Percutaneous Coronary Intervention)
Recruiting
- Acute Myocardial Infarction
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Belgrade, SerbiaClinical Centre of Serbia, Department of Cardiology
Mar 12, 2022
ST Elevation Myocardial Infarction Trial in Hangzhou (Intravascular Ultrasound (IVUS) -guided Primary Percutaneous Intervention
Recruiting
- ST Elevation Myocardial Infarction
- Intravascular Ultrasound (IVUS) -guided Primary Percutaneous Intervention (PCI)
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Aug 30, 2021
ST-Segment Elevation Myocardial Infarction Participants
Completed
- Coronary Artery Disease
- ST-segment Elevation Myocardial Infarction
-
Kaifeng, Contact:, China
- +35 more
Jan 6, 2022
No-Reflow Phenomenon Trial (1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol)
Not yet recruiting
- No-Reflow Phenomenon
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 13, 2021
Myocardial Infarction, Acute Trial in Mexico City (Primary percutaneous coronary intervention, Pharmacoinvasive strategy)
Completed
- Myocardial Infarction, Acute
- Primary percutaneous coronary intervention
- Pharmacoinvasive strategy
-
Mexico City, MexicoInstituto Nacional de Cardiología "Ignacio Chavez"
Jul 14, 2020
ST-elevation Myocardial Infarction Trial in Pavia (Evolocumab)
Withdrawn
- ST-elevation Myocardial Infarction
- Evolocumab
-
Pavia, PV, ItalyIRCCS Policlinico San Matteo
Apr 22, 2021
Stent Length and Diameter on Patients Undergoing Primary PCI
Unknown status
- ST-segment Elevation Myocardial Infarction (STEMI)
- (no location specified)
May 15, 2020
PRECISE DAPT Score in STEMI Patients After Primary PCI
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- calculate PRECISE DAPT score using clinical data
- (no location specified)
Sep 9, 2020
ST Elevation (STEMI) Myocardial Infarction Trial in Stavanger, Tromsø, Trondheim (Rosuvastatin, Simvastatin)
Completed
- ST Elevation (STEMI) Myocardial Infarction
-
Stavanger, Norway
- +2 more
Oct 20, 2020
Cardiovascular Diseases Trial in Rotterdam (Prasugrel (Crushed tablets), Prasugrel (Integral tablets))
Completed
- Cardiovascular Diseases
- Prasugrel (Crushed tablets)
- Prasugrel (Integral tablets)
-
Rotterdam, Netherlands
- +1 more
May 6, 2021
Myocardial Infarction Trial in Worldwide (Tenecteplase, Clopidogrel, Coronary angiography)
Active, not recruiting
- Myocardial Infarction
- Tenecteplase
- +3 more
-
Liverpool, Australia
- +49 more
Dec 20, 2022
Acute Insulin Resistance on Myocardial Blush in Non- Diabetic
Completed
- Insulin Resistance and PCI
- PCI
-
Assiut, EgyptFaculty of Medicine
Nov 26, 2020
Primary PCI Trial (ß -Blockers)
Not yet recruiting
- Primary PCI
- β -Blockers
- (no location specified)
Jan 7, 2020
Myocardial Infarction Trial in Beijing (guiding catheter, diagnostic catheter)
Completed
- Myocardial Infarction
- guiding catheter
- diagnostic catheter
-
Beijing, ChinaBeijing Luhe hospital
Jul 14, 2020